Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Review eligibility criteria for studies that interest you
Meet the weight-management clinical criteria (measured at the time GLP-1 therapy was first started): BMI of 35 or higher, or BMI of 30 or higher with heart failure (preserved ejection fraction), uncontrolled high blood pressure, or chronic kidney disease (stage 3a or above), or BMI of 27 or higher with prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease
Inert Gas Sealing: After removing the needed amount, reseal containers under dry, inert gas (e.g., nitrogen or argon) to prevent oxidation of remaining peptides
150 (Pt 7): 23272334
Analytical verification ensures that each batch meets the quality standards required for scientific investigation
These peptide agonists exert profound effects on overall metabolic health, influencing critical pathways that regulate glucose homeostasis, insulin sensitivity, and lipid metabolism
US$ 21.92
US$ 22.75
US$ 29.58
US$ 25.61
US$ 27.20
US$ 25.81
US$ 28.00
